Awards as PI
| Funding | ||
|---|---|---|
| Early Translational II | New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells | $5,665,887 |
| Basic Biology II | Cellular Reprogramming: Dissecting the Molecular Mechanism and Enhancing Efficiency | $1,458,000 |
Total: $7,123,887.00 |
